Kunio Iwatani
Director/Board Member chez MEDRX CO., LTD
Profil
Kunio Iwatani is an Independent Outside Director at Medrx Co., Ltd.
since 2016.
He was previously the President, CEO & Representative Director at Hokuriku Seiyaku Co., Ltd.
He also worked as a Director-International Product Management at Takeda Pharmaceutical Co., Ltd., Director at Abbott Japan LLC, President & Representative Director at Kringle Pharma, Inc. from 2003 to 2016, and Executive Vice President at TAP Pharmaceutical Products, Inc. Additionally, he served as Vice President at Takeda France SAS.
Postes actifs de Kunio Iwatani
| Sociétés | Poste | Début |
|---|---|---|
| MEDRX CO., LTD | Director/Board Member | 01/03/2016 |
Anciens postes connus de Kunio Iwatani
| Sociétés | Poste | Fin |
|---|---|---|
Abbott Japan LLC
 Abbott Japan LLC Drugstore ChainsRetail Trade Abbott Japan LLC manufactures and supplies pharmaceutical medicines. It manufactures medicines for nervous and respiratory agents. The company is headquartered in Tokyo, Japan. | Director/Board Member | - |
Hokuriku Seiyaku Co., Ltd.
 Hokuriku Seiyaku Co., Ltd. Pharmaceuticals: OtherHealth Technology Part of Abbott Laboratories, Hokuriku Seiyaku Co., Ltd. develops, manufactures, and sells pharmaceuticals. The private company is based in Katsuyama, Japan. Hokuriku Seiyaku Co. was acquired by Abbott Laboratories on June 30, 2002 for $291.31 million. | Chief Executive Officer | - |
Takeda France SAS
 Takeda France SAS Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda France SAS is a private company based in Paris, France. The CEOs are Anne-Sylvie Brunel, Sonia Rouges. Takeda France specializes in research and development for innovation in health, with expertise in gastroenterology, hematology, oncology, and rare diseases. The French company is committed to promoting information and studies requiring access to data by health manufacturers. Takeda France also has initiatives for diversity, equity, and inclusion, as well as a policy for the protection of personal data. The company was founded in 1978. | Corporate Officer/Principal | - |
TAP Pharmaceutical Products, Inc.
 TAP Pharmaceutical Products, Inc. Pharmaceuticals: MajorHealth Technology TAP Pharmaceutical Products, Inc. manufactures, develops, and markets pharmaceutical products. Its services include gastroenterology, gynecology, and urology. The company was founded in 1977 and is headquartered in Lake Forest, IL. | Corporate Officer/Principal | - |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| MEDRX CO., LTD | Health Technology |
| KRINGLE PHARMA, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Hokuriku Seiyaku Co., Ltd.
Hokuriku Seiyaku Co., Ltd. Pharmaceuticals: OtherHealth Technology Part of Abbott Laboratories, Hokuriku Seiyaku Co., Ltd. develops, manufactures, and sells pharmaceuticals. The private company is based in Katsuyama, Japan. Hokuriku Seiyaku Co. was acquired by Abbott Laboratories on June 30, 2002 for $291.31 million. | Health Technology |
Abbott Japan LLC
Abbott Japan LLC Drugstore ChainsRetail Trade Abbott Japan LLC manufactures and supplies pharmaceutical medicines. It manufactures medicines for nervous and respiratory agents. The company is headquartered in Tokyo, Japan. | Retail Trade |
TAP Pharmaceutical Products, Inc.
TAP Pharmaceutical Products, Inc. Pharmaceuticals: MajorHealth Technology TAP Pharmaceutical Products, Inc. manufactures, develops, and markets pharmaceutical products. Its services include gastroenterology, gynecology, and urology. The company was founded in 1977 and is headquartered in Lake Forest, IL. | Health Technology |
Takeda France SAS
Takeda France SAS Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda France SAS is a private company based in Paris, France. The CEOs are Anne-Sylvie Brunel, Sonia Rouges. Takeda France specializes in research and development for innovation in health, with expertise in gastroenterology, hematology, oncology, and rare diseases. The French company is committed to promoting information and studies requiring access to data by health manufacturers. Takeda France also has initiatives for diversity, equity, and inclusion, as well as a policy for the protection of personal data. The company was founded in 1978. | Health Technology |
